We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRACU
12626
DELISTED
Marquee Raine Acquisition Corp. Unit
MRACU
$118K ﹤0.01%
11,468
-2,860
-20% -$28.9K
NAVB
12627
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$118K ﹤0.01%
64,643
+10,129
+19% +$17.9K
CABA icon
12628
CALL
Cabaletta Bio
CABA
$466M
$117K ﹤0.01%
+13,600
New +$134K
ENLV icon
12629
CALL
Enlivex Ltd
ENLV
$26.6M
$117K ﹤0.01%
873
-207
-19% -$31.1K
VHAQ.U
12630
DELISTED
Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock
VHAQ.U
$117K ﹤0.01%
+11,079
New +$115K
GIIXW
12631
DELISTED
Gores Holdings VIII, Inc. Warrant
GIIXW
$117K ﹤0.01%
+93,750
New +$107K
HBP
12632
PUT
DELISTED
Huttig Building Products, Inc.
HBP
$117K ﹤0.01%
20,300
-13,700
-40% -$72.5K
YSAC
12633
DELISTED
Yellowstone Acquisition Company
YSAC
$117K ﹤0.01%
+11,630
New +$117K
PNNT
12634
CALL
Pennant Park Investment Corp
PNNT
$243M
$116K ﹤0.01%
+17,300
New +$113K
UBX
12635
CALL
DELISTED
Unity Biotechnology
UBX
$116K ﹤0.01%
+2,510
New +$121K
YARW
12636
CALL
Yarrow Bioscience
YARW
$113M
$116K ﹤0.01%
37
-30
-45% -$119K
YARW
12637
Yarrow Bioscience
YARW
$113M
$116K ﹤0.01%
+37
New +$146K
QUMU
12638
CALL
DELISTED
Qumu Corp.
QUMU
$116K ﹤0.01%
+40,200
New +$198K
COLIW
12639
DELISTED
Colicity Inc. Warrant
COLIW
$116K ﹤0.01%
+74,999
New +$98.9K
TUFN
12640
CALL
DELISTED
Tufin Software Technologies Ltd.
TUFN
$116K ﹤0.01%
+12,700
New +$119K
GRCYU
12641
DELISTED
Greencity Acquisition Corporation Unit
GRCYU
$116K ﹤0.01%
+11,127
New +$116K
EPM icon
12642
PUT
Evolution Petroleum
EPM
$135M
$115K ﹤0.01%
23,200
+10,500
+83% +$41.3K
IGC icon
12643
PUT
IGC Pharma
IGC
$31.1M
$115K ﹤0.01%
70,200
-12,900
-16% -$19.7K
PGRE
12644
CALL
DELISTED
Paramount Group
PGRE
$115K ﹤0.01%
+11,400
New +$121K
UCL
12645
uCloudlink Group
UCL
$27.8M
$115K ﹤0.01%
11,527
-16,985
-60% -$187K
SRNGW
12646
DELISTED
Soaring Eagle Acquisition Corp. Warrant
SRNGW
$115K ﹤0.01%
+34,839
New +$87.3K
ORBC
12647
PUT
DELISTED
ORBCOMM, Inc.
ORBC
$115K ﹤0.01%
10,200
-46,800
-82% -$519K
TIO
12648
DELISTED
Tingo Group, Inc. Common Stock
TIO
$115K ﹤0.01%
49,381
-71,705
-59% -$138K
HEPA
12649
DELISTED
Hepion Pharmaceuticals
HEPA
$114K ﹤0.01%
58
+31
+115% +$56.7K
SID icon
12650
PUT
Companhia Siderúrgica Nacional
SID
$1.17B
$114K ﹤0.01%
+13,000
New +$113K
504 505
506
507 508

Similar funds

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.